Entera Bio Ltd

General ticker "ENTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $73.4M

Entera Bio Ltd follows the US Stock Market performance with the rate: 29.0%.

Estimated limits based on current volatility of 3.9%: low 2.02$, high 2.19$

Factors to consider:

  • Current price 57.2% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.46$, 1.27$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.69$, 1.70$]

Financial Metrics affecting the ENTX estimates:

  • Negative: Non-GAAP EPS, $ of -0.31 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -27.05 <= 2.35
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term ENTX quotes

Long-term ENTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.62MM $0.18MM $0.00MM
Operating Expenses $12.83MM $13.20MM $8.89MM
Operating Income $-12.22MM $-13.02MM $-8.89MM
Non-Operating Income $-0.03MM $0.08MM $0.03MM
Interest Expense $0.03MM $0.00MM $0.00MM
R&D Expense $6.77MM $5.85MM $4.51MM
Income(Loss) $-12.25MM $-12.93MM $-8.86MM
Taxes $-0.06MM $0.14MM $0.03MM
Profit(Loss) $-12.19MM $-13.07MM $-8.89MM
Stockholders Equity $22.57MM $11.75MM $10.39MM
Inventory $0.00MM $0.29MM $0.00MM
Assets $25.99MM $13.13MM $11.77MM
Operating Cash Flow $-9.06MM $-12.50MM $-7.31MM
Capital expenditure $0.02MM $0.05MM $0.02MM
Investing Cash Flow $-0.02MM $-0.10MM $-0.02MM
Financing Cash Flow $25.38MM $0.01MM $6.04MM
Earnings Per Share* $-0.47 $-0.45 $-0.31

* EPS are Split Adjusted, recent splits may be reflected with a delay.